Literature DB >> 32686636

Ten-year course of cognition in first-episode non-affective psychosis patients: PAFIP cohort.

José Manuel Rodríguez-Sánchez1,2, Esther Setién-Suero2,3, Paula Suárez-Pinilla2,3, Jaqueline Mayoral Van Son2, Javier Vázquez-Bourgon2,3, Patxi Gil López1, Benedicto Crespo-Facorro2,4, Rosa Ayesa-Arriola2,3.   

Abstract

BACKGROUND: A large body of research states that cognitive impairment in schizophrenia is static. Nevertheless, most previous studies lack a control group or have small study samples or short follow-up periods.
METHOD: We aimed to address these limitations by studying a large epidemiological cohort of patients with first-episode schizophrenia spectrum disorders and a comparable control sample for a 10-year period.
RESULTS: Our results support the generalized stability of cognitive functions in schizophrenia spectrum disorders considering the entire group. However, the existence of a subgroup of patients characterized by deteriorating cognition and worse long-term clinical outcomes must be noted. Nevertheless, it was not possible to identify concomitant factors or predictors of deterioration (all Ps > 0.05).
CONCLUSIONS: Cognitive functions in schizophrenia spectrum disorder are stable; however, a subgroup of subjects that deteriorate can be characterized.

Entities:  

Keywords:  10-year follow-up; cognition; first-episode psychosis; stability

Mesh:

Year:  2020        PMID: 32686636     DOI: 10.1017/S0033291720002408

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  1 in total

1.  Cognitive and Global Functioning in Patients With First-Episode Psychosis Stratified by Level of Negative Symptoms. A 10-Year Follow-Up Study.

Authors:  Magnus Johan Engen; Anja Vaskinn; Ingrid Melle; Ann Færden; Siv Hege Lyngstad; Camilla Bärthel Flaaten; Line Hustad Widing; Kristin Fjelnseth Wold; Gina Åsbø; Beathe Haatveit; Carmen Simonsen; Torill Ueland
Journal:  Front Psychiatry       Date:  2022-03-25       Impact factor: 4.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.